Literature DB >> 20012135

The disease burden of colorectal cancer in Hungary.

Imre Boncz1, Valentin Brodszky, Márta Péntek, István Agoston, Zsolt Nagy, Krisztián Kárpáti, Ildikó Kriszbacher, Péter Fuszek, László Gulácsi.   

Abstract

The aim of the paper is to give an overview of the epidemiology, treatment pattern and quality, as well as policy issues and disease burden of colorectal cancer (CRC) in Hungary. Colorectal cancer is the second most common cause of cancer-related death in both males and females in Hungary. The Hungarian Cancer Registry collects data on the epidemiological characteristics of CRC. Two pilot programmes (1997/1998 and 2003/2004) were conducted for population-based screening of CRC using both immunological and guaiac faecal occult blood testing (FOBT). The National Health Insurance Fund Administration (NHIFA) spends altogether <euro> 38.9 million a year on the treatment of CRC. It is hoped that the introduction of an accepted and cost-effective screening programme for CRC can reduce the high CRC burden in Hungary.

Entities:  

Mesh:

Year:  2010        PMID: 20012135     DOI: 10.1007/s10198-009-0192-z

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  22 in total

1.  [Health economics analysis of colorectal screening].

Authors:  Imre Boncz; Andor Sebestyén; Csaba Dózsa; Miklós Pál; János Sándor; Judit Palásti; József Betlehem; István Ember
Journal:  Magy Onkol       Date:  2004-09-07

Review 2.  [Trends in cancer mortality and morbidity in Hungarian and international statistics. Characteristics and potential outcome of public health screening programs].

Authors:  Szabolcs Ottó; Miklós Kásler
Journal:  Magy Onkol       Date:  2005-10-24

3.  Financial deficits in the health services of the UK and Hungary.

Authors:  Imre Boncz; Andor Sebestyén
Journal:  Lancet       Date:  2006-09-09       Impact factor: 79.321

4.  Prevention of cervical cancer in low-resource settings.

Authors:  Imre Boncz
Journal:  JAMA       Date:  2006-03-15       Impact factor: 56.272

5.  Organized, nationwide cervical cancer screening programme in Hungary.

Authors:  Imre Boncz; Andor Sebestyén; István Ember
Journal:  Gynecol Oncol       Date:  2007-04-30       Impact factor: 5.482

6.  The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities.

Authors:  Imre Boncz; Andor Sebestyén; István Pintér; István Battyány; István Ember
Journal:  J Med Screen       Date:  2008       Impact factor: 2.136

7.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

8.  Rectal cancer therapy: decision making on basis of quality of life?

Authors:  R Harisi; G Bodoky; M Borsodi; L Flautner; J Weltner
Journal:  Zentralbl Chir       Date:  2004-04       Impact factor: 0.942

9.  Double immunochemical screening test (hemoglobin and albumin) for the detection of occult intestinal bleeding.

Authors:  S Otto; M Nemeth
Journal:  J Clin Lab Anal       Date:  1993       Impact factor: 2.352

10.  [Survival chances of Hungarian cancer patients in the National Cancer Registry].

Authors:  Gábor Tusnády; István Gaudi; Lídia Rejto; Miklós Kásler; Zoltán Szentirmay
Journal:  Magy Onkol       Date:  2008-12
View more
  9 in total

1.  Future challenges for health economics and health technology assessment of biological drugs.

Authors:  László Gulácsi
Journal:  Eur J Health Econ       Date:  2010-06

2.  The influence of waiting times on cost-effectiveness: a case study of colorectal cancer mass screening.

Authors:  Pauline Chauvin; Jean-Michel Josselin; Denis Heresbach
Journal:  Eur J Health Econ       Date:  2013-08-22

3.  The dynamics of colorectal cancer management in 17 countries.

Authors:  Panos Kanavos; Willemien Schurer
Journal:  Eur J Health Econ       Date:  2010-01

4.  Estimation of incidence, prevalence, and age-at-diagnosis of myasthenia gravis among adults by hospital discharge records.

Authors:  Anett Foldvari; Nora Kovacs; Valeria Sipos; Gabriella Merth; Ferenc Vincze; Maria Szucs; Janos Sandor
Journal:  Wien Klin Wochenschr       Date:  2015-05-20       Impact factor: 1.704

5.  Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).

Authors:  Miroslava Katičić; Nataša Antoljak; Milan Kujundžić; Valerija Stamenić; Dunja Skoko Poljak; Danica Kramarić; Davor Stimac; Marija Strnad Pešikan; Mirko Samija; Zdravko Ebling
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

Review 6.  Economic studies in colorectal cancer: challenges in measuring and comparing costs.

Authors:  K Robin Yabroff; Laurel Borowski; Joseph Lipscomb
Journal:  J Natl Cancer Inst Monogr       Date:  2013

Review 7.  The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.

Authors:  Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Layal Chaker; Sven J van der Lee; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Abby Falla; Raha Pazoki; Oscar H Franco
Journal:  Eur J Epidemiol       Date:  2015-01-18       Impact factor: 8.082

8.  Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum.

Authors:  Mariann Rutka; Renáta Bor; Anita Bálint; Anna Fábián; Ágnes Milassin; Ferenc Nagy; Zoltán Szepes; Mónika Szűcs; László Tiszlavicz; Klaudia Farkas; Tamás Molnár
Journal:  Mediators Inflamm       Date:  2016-06-16       Impact factor: 4.711

9.  Significance of preoperative blood tests in the prognosis of colorectal cancer: A prospective, multicenter study from Hungary.

Authors:  Adrienn Biró; Péter Kolozsi; Attila Nagy; Zsolt Varga; Zsolt Káposztás; Dezső Tóth
Journal:  J Clin Lab Anal       Date:  2021-11-23       Impact factor: 2.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.